Skip to content
Forensic Analysis · Fabless · as of Nov 11, 2026

Silicon Laboratories Inc. (SLAB)

A forensic read on Silicon Laboratories Inc. built from its complete SEC filings — financial-health screens, earnings quality, red flags and a price-aware rating. Reproducible math, not opinion.

D · Weak — demands caution
Forensic grade
Safe
Financial health
11.3
Distress distance
Clean
Earnings quality
2
Forensic signals
-6.0%
ROE
34.3%
Revenue growth

This free snapshot doesn't read filing or proxy text, so the auditor-quality and governance checks that can lower a grade were not evaluated (auditor quality, say on pay, board independence, going concern). Those checks only ever lower a grade, so the full analysis can land below the grade above but never above it — treat it as the most favourable reading, not the settled one.

Silicon Laboratories Inc. earns a D (Weak — demands caution) forensic quality grade, and its balance-sheet distress test reads 11.3, placing it in the Safe zone. 2 forensic signals were flagged in its latest SEC filings, led by return on invested capital.

What the filings flag

-6.9%
FY2025
Return on invested capital. Return on invested capital is -6.9% in the latest fiscal year, against -1.8% in FY2023, having run between -13.8% and -1.8% across FY2023–FY2025 with no direction held. After-tax operating profit was ($19M) in FY2023 and ($56M) in FY2025, with operating income at -3.1% of revenue in FY2023, -28.3% in FY2024 and -9.0% in FY2025. The capital base behind it came down -24% across FY2023–FY2025, from $1.1B to $802M, so this return is struck on a smaller base than it started on. $90M of the $802M base at FY2025 is short-term investments (11.2%) — securities held beside cash, which the base keeps because only cash is subtracted from it; they earn the balance sheet's yield, which is not in the operating profit above, so the loss on the operating capital is larger than this rate shows.
stopped
FY2023→FY2025
Shareholder returns — halted. Capital returns have STOPPED — $217M of buybacks + dividends in FY2023, but ~$0 in FY2025. A halt usually means the company is conserving cash.

Key fundamentals

Latest Revenue$784.8M
Revenue Growth YoY+34.3%
Revenue CAGR (2yr)+0.2%
Net Margin-8.3%
Free Cash Flow$65.8M
Return on Equity-6.0%

The forensic grade and screens above are free — no account needed. Want the AI investment read on top — the 0–100 rating, thesis, bull-vs-bear, red flags and the 12-month scenario, written from Silicon Laboratories Inc.'s actual 10-K/10-Q/8-K filings?

Generate the AI investment read →

No credit card · informational only, not investment advice · see the track record

← Browse all forensic stock analyses

Data from SEC EDGAR public filings · metrics as of Nov 11, 2026. Forensic signals flag probability, not certainty.

See a wrong number? Report an error with the filing it should match.